New Appointments Made to hyperCORE International Executive Board
October 20, 2022
With this year’s additions of new alliance partners, hyperCORE International has recently expanded their Executive Board to include new appointments that will help the super network continue to build new clinical research site and Sponsor relationships, expand existing industry relationships, and create new opportunities for continued success.
New appointments to the Executive Board include:
Carlos Orantes, CEO of Alcanza Clinical Research, as Co-Chief Diversity Officer (alongside Seneca Harrison)
Dr. Samir Arora, President of Aventiv Research, as Chief Corporate Development Officer
Michael Casey as Executive Director of hyperCORE International
With a total of 12 appointments and seasoned executives with an extensive amount of clinical research experience, hyperCORE has positioned its super network to be the one-stop solution for clinical trials and greatly accelerate its growth.